NCT00408668View on ClinicalTrials.gov

Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

February 28, 2006

Conditions
MalariaMalaria, Falciparum
Interventions
BIOLOGICAL

PEV3A

BIOLOGICAL

FP9 ME-TRAP

BIOLOGICAL

MVA ME-TRAP

Trial Locations (1)

OX3 7LJ

Centre for Clinical Vaccinology and Tropical Medicine, Oxford

Sponsors
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

collaborator

Pevion Biotech Ltd

INDUSTRY

collaborator

Swiss Tropical & Public Health Institute

OTHER

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

lead

University of Oxford

OTHER

NCT00408668 - Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen | Biotech Hunter | Biotech Hunter